drugset / Trial / NCT00110916
Treatment for Patients With Osteoarthritis (OA) of the Knee
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the clinical response in subjects with symptomatic OA of the knee following a single 50 mg anakinra, 150 mg anakinra or placebo intra-articular (IA) injection.
Timeline
- Start
- 2004-06
- Primary completion
- 2005-02
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anakinra | Protein / enzyme biologic | 50 mg | Other |
| Subject | Anakinra | Protein / enzyme biologic | 150 mg | Other |